01:59 PM EDT, 06/20/2025 (MT Newswires) -- Health care stocks declined Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both shedding 0.4%.

The iShares Biotechnology ETF (IBB) dropped 0.3%.

In corporate news, Eli Lilly ( LLY ) plans to appeal against the UK's National Institute for Health and Care Excellence's decision not to reimburse the cost of Alzheimer's drug Kisunla under the National Health Service. Eli Lilly ( LLY ) shares fell 2.4%.

Sarepta Therapeutics ( SRPT ) shares fell 3% after William Blair downgraded the stock to market perform from outperform.

Argenx (ARGX) shares rose 1.2% after the company said its Vyvgart injectable monotherapy to treat chronic inflammatory demyelinating polyneuropathy in adults has received EU approval.